Get Your Personalized Supplement StackSupplement Stack Quiz

Cynanchum

Also known as: Cynanchum, swallow-wort, dog-strangling vine, Cynanchum atratum

Overview

Cynanchum refers to a genus of plants traditionally used in Asian herbal medicine, with *Cynanchum atratum* being the most studied species for its potential therapeutic effects. It is primarily investigated for its anti-inflammatory properties, ability to regulate lipid metabolism, and liver protection. While research is emerging, the current evidence base is largely derived from preclinical (animal and in vitro) studies, with limited human clinical trials. It is considered an herbal supplement and a traditional medicinal plant extract. The overall quality of evidence supporting its use is moderate to low, and comprehensive systematic reviews or meta-analyses specifically on Cynanchum as a supplement ingredient are not yet available.

Benefits

Preclinical studies, particularly using *Cynanchum atratum* ethanol extract (CAE), have demonstrated potential benefits in ameliorating non-alcoholic fatty liver disease (NAFLD). In a 10-week high-fat, high-fructose diet mouse model, CAE was shown to balance lipid metabolism and enhance fatty acid oxidation, leading to a reduction in fatty liver. It also improved hyperglycemia, hyperlipidemia, and hepatic inflammation, partly by reducing endotoxins from gut bacteria. These metabolic benefits are likely mediated through the activation of AMPK and PPARα pathways. However, it is crucial to note that these findings are from animal models, and there are no high-quality randomized controlled trials (RCTs) or meta-analyses in humans to quantify effect sizes or clinical significance in populations with metabolic diseases. Therefore, the strength of evidence for human benefits is currently low.

How it works

Cynanchum's mechanism of action primarily involves the activation of key metabolic regulators: AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPARα). These pathways are crucial for regulating lipid metabolism and fatty acid oxidation, which in turn contribute to improved lipid profiles, reduced fat accumulation in the liver, and decreased inflammatory responses. Additionally, the extract appears to modulate gut microbiota-derived endotoxins, which can reduce hepatic inflammation. The exact absorption and bioavailability characteristics of Cynanchum compounds in humans are not yet well understood or characterized.

Side effects

A comprehensive safety profile for Cynanchum in humans is currently unavailable due to a lack of sufficient clinical trials. While animal studies suggest tolerability at the doses tested, there is no robust human safety data regarding common or rare adverse effects, potential drug interactions, or contraindications. No reports of adverse effects in clinical settings were found in the provided research. Therefore, the full spectrum of potential side effects, severity, frequency, and specific risk factors remains largely unknown. Caution is advised until more extensive human safety data becomes available.

Dosage

There are no established dosing guidelines for Cynanchum supplements in humans due to the insufficient clinical data. Preclinical studies have utilized ethanol extracts in animal models, but translating these doses to safe and effective human equivalent doses requires further research and rigorous clinical trials. Without human-specific data, recommended dosage ranges, timing considerations, dosages for different purposes, and information on absorption factors or upper safety limits cannot be provided. Any use of Cynanchum should be approached with caution and under professional guidance, given the lack of established human dosing and safety information.

FAQs

Is Cynanchum safe for human use?

Safety in humans is not well established due to a lack of clinical trials. Caution is advised until rigorous human studies confirm its safety profile and potential side effects.

What conditions might Cynanchum help?

Preliminary evidence from animal studies suggests potential benefits in non-alcoholic fatty liver disease (NAFLD) and metabolic regulation, but human efficacy is unproven.

How long before effects appear?

Animal studies used interventions lasting 10 weeks. The timeline for potential effects in humans is currently unknown and requires further research.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC8750091/ – This preclinical animal study investigated the effects of *Cynanchum atratum* ethanol extract (CAE) in mice on a high-fat, high-fructose diet. It found that CAE reduced fatty liver, improved lipid metabolism, and decreased inflammation by activating AMPK and PPARα pathways. The study provides moderate preclinical evidence for potential metabolic benefits but is limited by its animal model and lack of human data.